What Peptides Actually Are: Structure, Chain Length and Classification

The short answer

A peptide is a chain of amino acids joined by amide bonds, conventionally called peptide bonds. The distinction between a peptide, a polypeptide and a protein is one of convention and chain length rather than a sharp chemical boundary, with most authors placing the peptide/protein transition somewhere around 50 residues. Chain length, sequence and the chemical character of the individual side chains determine how a given peptide behaves in solution, how readily it degrades, and how difficult it is to synthesise and characterise.

Amino acids and the peptide bond

The building blocks of peptides are alpha-amino acids: molecules carrying both an amino group and a carboxylic acid group attached to the same carbon, along with a variable side chain. Twenty amino acids are encoded genetically in most organisms, and a much larger set of non-proteinogenic and chemically modified amino acids is used in synthetic work.

A peptide bond forms when the carboxyl group of one amino acid condenses with the amino group of another, releasing a molecule of water. The resulting amide linkage is unusually stable for an amide because the nitrogen lone pair delocalises into the carbonyl. That delocalisation gives the bond partial double-bond character, restricting rotation and holding the six atoms of the peptide unit approximately planar. Rotation is instead concentrated at the two flanking single bonds, described by the torsion angles phi and psi, and the permitted combinations of those angles are what Ramachandran plots map.

Because the bond is directional, every linear peptide has two distinct termini: a free amino group at one end (the N-terminus) and a free carboxyl group at the other (the C-terminus). Sequences are written N-terminus first by convention, which is why the order in which residues are listed matters and why two peptides containing identical amino acids in different orders are entirely different compounds.

Where peptides end and proteins begin

There is no chemical event that occurs at a particular chain length to convert a peptide into a protein. The terminology is descriptive and, to a degree, arbitrary. In common usage:

• Oligopeptide is generally applied to short chains, often up to around ten residues.
• Polypeptide covers longer chains that are still usually discussed as sequences rather than as folded structures.
• Protein tends to be used once a chain is long enough to adopt a stable, defined three-dimensional fold, frequently cited as roughly 50 residues or more.

Different sources place these boundaries differently, and some molecules sit awkwardly across them. Insulin, at 51 residues across two chains, is routinely described as a protein by some authors and a polypeptide hormone by others. The practical point for laboratory work is that the label carries no analytical meaning: purity, identity and stability must be established empirically regardless of what the compound is called.

Primary structure and the levels above it

Primary structure is simply the covalent sequence of residues, including any disulfide bridges between cysteine side chains and any post-translational or synthetic modifications such as amidation, acetylation, phosphorylation or glycosylation. It is the level of structure that a synthesis is designed to produce and that mass spectrometry is used to confirm.

Secondary structure refers to local, hydrogen-bonded motifs such as alpha helices and beta sheets. Tertiary structure is the overall three-dimensional arrangement of a single chain, and quaternary structure describes assemblies of multiple chains. Short peptides frequently have little persistent secondary structure in dilute aqueous solution, existing instead as an ensemble of rapidly interconverting conformations; some adopt more defined structures on binding to a partner molecule, in membrane-mimetic environments, or at higher concentrations. This conformational flexibility is one reason that structural characterisation of short peptides is often harder than for folded proteins.

Naturally occurring versus synthetic peptides

Peptides occur throughout biology, where they function as hormones, neurotransmitters and neuromodulators, antimicrobial agents, toxins and signalling intermediates. Many are produced by ribosomal translation followed by proteolytic processing of a larger precursor; others, including a number of bacterial and fungal peptides, are assembled by non-ribosomal peptide synthetases and may contain D-amino acids, N-methylated residues or cyclic structures that the ribosome cannot generate.

Synthetic peptides used in research fall into several categories: exact reproductions of natural sequences, fragments of larger proteins, and analogues in which residues have been substituted, deleted, cyclised or replaced with non-natural amino acids. Analogue design is common in structure-activity research, where the objective is to determine which residues are required for a given interaction. It should be noted that a synthetic peptide reproducing a natural sequence is chemically the same compound as the natural material only if the synthesis has in fact delivered the intended sequence, with correct stereochemistry and correct disulfide connectivity where relevant — none of which can be assumed without analysis.

Why chain length affects stability and handling

Longer sequences present more opportunities for degradation simply because they contain more susceptible sites. Every peptide bond is in principle hydrolysable; methionine, cysteine and tryptophan side chains are oxidation-prone; asparagine and glutamine residues can deamidate; and aspartate-glycine motifs are recognised sites for isomerisation and chain cleavage. Length also increases the probability that a chain will contain a segment prone to aggregation.

Chain length affects synthesis and analysis as well. Stepwise chemical synthesis accumulates small errors at each cycle, so overall yield and purity fall as the sequence lengthens. Longer chains are harder to resolve chromatographically from closely related deletion sequences, and their mass spectra are more crowded. Solubility behaviour also becomes less predictable: a short, highly charged peptide may dissolve readily in water while a longer hydrophobic sequence may require careful solvent selection to avoid aggregation. These are the practical reasons that handling protocols are usually written per compound rather than generically.

Research use only

The products discussed on this site are supplied strictly for laboratory research use only. They are not medicines, are not licensed or approved for human or veterinary consumption, and must not be administered to humans or animals. Nothing in this article constitutes medical advice, a therapeutic claim, or a recommendation for use of any kind. Information is provided for the purpose of describing published chemistry and research findings, and should not be interpreted as evidence of safety or efficacy for any application.

Image: “VIR-576 3D” by BQUB13-Ccomesaña, licensed under CC BY-SA 3.0.